News
TEVA
33.91
-0.91%
-0.31
Teva Pharmaceutical Industries Ltd. Files Initial Beneficial Ownership Statement for Interim Chief Legal Officer Brian Savage
Reuters · 3h ago
FDA Accepts Teva's New Long-Acting Schizophrenia Treatment Application
Benzinga · 10h ago
Novo Nordisk: Why Wegovy Growth Beats Wall Street Expectations
Seeking Alpha · 11h ago
Weekly Report: what happened at TEVA last week (0216-0220)?
Weekly Report · 15h ago
Assessing Teva Pharmaceutical Industries (NYSE:TEVA) Valuation After Its Strong Recent Share Price Momentum
Simply Wall St · 19h ago
Teva, Medincell granted FDA review for long-acting antipsychotic
Seeking Alpha · 2d ago
FDA Accepts NDA For Teva And Medincell's Olanzapine LAI In Schizophrenia Treatment
NASDAQ · 2d ago
FDA accepts Teva and Medincell’s NDA for TEV-’749 olanzapine monthly injectable
Reuters · 3d ago
FDA accepts Teva NDA for olanzapine extended-release injectable suspension
TipRanks · 3d ago
FDA accepts Teva NDA for TEV-’749 olanzapine once-monthly injectable for schizophrenia
Reuters · 3d ago
Price Over Earnings Overview: Teva Pharmaceutical Indus
Benzinga · 3d ago
Teva management to meet with Piper Sandler
TipRanks · 3d ago
U.S. Food and Drug Administration (FDA) Accepts Teva’s New Drug Application (NDA) for Olanzapine Extended-Release Injectable Suspension (TEV-'749) for the Once-Monthly Treatment of Schizophrenia in Adults
Barchart · 3d ago
Corcept Therapeutics: The Bad News Is Priced In; The Ovarian Cancer Upside Is Not
Seeking Alpha · 3d ago
Corcept Therapeutics price target lowered to $67 from $105 at H.C. Wainwright
TipRanks · 3d ago
Allspring Mid Cap Growth Fund Q4 2025 Performance Insights, Portfolio Drivers & Decisions
Seeking Alpha · 3d ago
Corcept ‘disappointed’ in court ruling over Teva patent dispute
TipRanks · 4d ago
*Corcept Therapeutics: Court of Appeals Found Teva Pharmaceuticals' Marketing of Generic Version of Korlym Does Not Infringe Two of Corcept's Patents >CORT
Dow Jones · 4d ago
*Corcept Therapeutics: Ruling Affirms a Dec 2023 Verdict by the Federal District Court for the District of New Jersey >CORT
Dow Jones · 4d ago
*Corcept Therapeutics: Disappointed in the Court's Ruling >CORT
Dow Jones · 4d ago
More
Webull provides a variety of real-time TEVA stock news. You can receive the latest news about Teva Pharm through multiple platforms. This information may help you make smarter investment decisions.
About TEVA
Teva Pharmaceutical Industries Ltd is a Israeli-based pharmaceutical company. The Company operates through three segments: North America, Europe and International Markets. Each business segment manages entire product portfolio in its region, including generics, specialty and over-the-counter (OTC) products. In addition to these three segments, The Company has other activities, primarily the sale of active pharmaceutical ingredients (API) to third parties, certain contract manufacturing services and an out-licensing platform offering a portfolio of products to other pharmaceutical companies through its affiliate Medis.